Patents by Inventor Haihong Huang

Haihong Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11214029
    Abstract: Disclosed is a double-motor double-station screw press, comprising two sets of screw pair mechanisms on both sides thereof, i.e., first and second screw pair mechanisms, where in the first screw pair mechanism, a first lead screw is driven by a resultant movement synthesized by first and second motors through a first differential gear train; in the second screw pair mechanism, a second lead screw is driven by a resultant movement synthesized by the first and second motors through a second differential gear train; a first slider and a second slider in the press work symmetrically; a transmission mode between the second motor and the second differential gear train is switched by controlling a steering switching apparatus, such that the second motor can assist the first motor during a single-cylinder pressing process to increase the output pressure, but also it is convenient to adjust a relative positions of two cylinders.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: January 4, 2022
    Assignee: HEFEI UNIVERSITY OF TECHNOLOGY
    Inventors: Haihong Huang, Rui Jin, Lei Li, Bo Fang, Zhifeng Liu
  • Patent number: 11186057
    Abstract: A press machine is provided. Two vertical hydraulic cylinders are arranged on an upper beam plate of a press machine body, and the two hydraulic cylinders correspond to workbenches at corresponding positions in a one-to-one correspondence, constituting left and right working units, and a common mechanical drive unit and a common hydraulic drive unit are set for the left and right working units. The mechanical driving unit is composed of a driving motor through an electromagnetic clutch, an electromagnetic brake and lead screw nut driving mechanism driven by a gear pair. According to the load profiles during the working process of hydraulic press machine, the mechanical driving unit or the hydraulic driving unit are selected to provide energy for the two working units. A control method for the press machine, a press machine execution system and a control method for the press machine execution system are further involved.
    Type: Grant
    Filed: September 9, 2019
    Date of Patent: November 30, 2021
    Assignee: HEFEI UNIVERSITY OF TECHNOLOGY
    Inventors: Haihong Huang, Lei Li, Zhicheng Cao, Zhifeng Liu
  • Publication number: 20210271216
    Abstract: Disclosed are an energy service system of a multi-machine production line and a control method thereof, the method includes reorganizing respective machines in the production line into three types of controllable entities: a drive system, an energy supply bus and an execution device, equipping them with a control center, and selecting a sub-drive system that is idle and is capable of completing the work stage with high energy efficiency to supply energy service for the corresponding execution device through the energy supply bus. Further disclosed is a design method of a multi-machine shared drive system of a production line, which increases the number of basic flow units of each drive unit to a maximum value one by one, and coordinates action time to form a variety of scheduling schemes, and selects a configuration scheme whose total time and total energy consumption are less as the shared drive system.
    Type: Application
    Filed: May 19, 2021
    Publication date: September 2, 2021
    Inventors: Haihong HUANG, Xiang ZOU, Lei LI, Libin ZHU, Zhifeng LIU
  • Publication number: 20210188871
    Abstract: The present invention discloses a nitrogen-containing heterocyclic substituted benzoxazine oxazolidinone compound, a preparation method and use thereof in the manufacture of a medicament for treating and/or preventing infectious diseases caused by Mycobacterium tuberculosis. Specifically, the present invention relates to a compound represented by formula (I) and stereoisomer thereof, pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compounds of the present invention, use thereof, a method for preparing the compound, in which X1, X2, R1 and R2 are described in the specification.
    Type: Application
    Filed: March 28, 2018
    Publication date: June 24, 2021
    Applicant: INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Haihong HUANG, Dongfeng ZHANG, Hongyi ZHAO
  • Publication number: 20200189220
    Abstract: Disclosed is a double-motor double-station screw press, comprising two sets of screw pair mechanisms on both sides thereof, i.e., first and second screw pair mechanisms, where in the first screw pair mechanism, a first lead screw is driven by a resultant movement synthesized by first and second motors through a first differential gear train; in the second screw pair mechanism, a second lead screw is driven by a resultant movement synthesized by the first and second motors through a second differential gear train; a first slider and a second slider in the press work symmetrically; a transmission mode between the second motor and the second differential gear train is switched by controlling a steering switching apparatus, such that the second motor can assist the first motor during a single-cylinder pressing process to increase the output pressure, but also it is convenient to adjust a relative positions of two cylinders.
    Type: Application
    Filed: February 24, 2020
    Publication date: June 18, 2020
    Inventors: Haihong Huang, Rui Jin, Lei Li, Bo Fang, Zhifeng Liu
  • Publication number: 20200148651
    Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
    Type: Application
    Filed: January 13, 2020
    Publication date: May 14, 2020
    Inventors: Christopher B. COOPER, Haihong HUANG, Dongfeng ZHANG, Nader FOTOUHI, Takushi KANEKO
  • Patent number: 10550092
    Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: February 4, 2020
    Assignee: The Global Alliance for TB Drug Development, Inc.
    Inventors: Christopher B. Cooper, Haihong Huang, Dongfeng Zhang, Nader Fotouhi, Takushi Kaneko
  • Publication number: 20200001563
    Abstract: A press machine is provided. Two vertical hydraulic cylinders are arranged on an upper beam plate of a press machine body, and the two hydraulic cylinders correspond to workbenches at corresponding positions in a one-to-one correspondence, constituting left and right working units, and a common mechanical drive unit and a common hydraulic drive unit are set for the left and right working units. The mechanical driving unit is composed of a driving motor through an electromagnetic clutch, an electromagnetic brake and lead screw nut driving mechanism driven by a gear pair. According to the load profiles during the working process of hydraulic press machine, the mechanical driving unit or the hydraulic driving unit are selected to provide energy for the two working units. A control method for the press machine, a press machine execution system and a control method for the press machine execution system are further involved.
    Type: Application
    Filed: September 9, 2019
    Publication date: January 2, 2020
    Inventors: Haihong Huang, Lei Li, Zhicheng Cao, Zhifeng Liu
  • Publication number: 20180179168
    Abstract: The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
    Type: Application
    Filed: July 15, 2016
    Publication date: June 28, 2018
    Inventors: Christopher B. COOPER, Haihong HUANG, Dongfeng ZHANG, Nader FOTOUHI, Takushi KANEKO
  • Patent number: 9174996
    Abstract: The present invention relates to compounds of Formula VIII with absolute configuration R or S: as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: November 3, 2015
    Assignee: Astar Biotech LLC
    Inventors: Chunrong Yu, Haihong Huang, Dongfeng Zhang, Peng Li
  • Publication number: 20140364436
    Abstract: The present invention relates to compounds of Formula VIII with absolute configuration R or S: as well as pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula VIII, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
    Type: Application
    Filed: August 26, 2014
    Publication date: December 11, 2014
    Applicant: ASTAR BIOTECH LLC
    Inventors: Chunrong YU, Haihong HUANG, Dongfeng ZHANG, Peng LI
  • Patent number: 8859553
    Abstract: The present invention relates to compounds of Formula I: as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula I, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: October 14, 2014
    Assignee: Astar Biotech LLC
    Inventors: Chunrong Yu, Haihong Huang, Dongfeng Zhang, Peng Li
  • Publication number: 20140243327
    Abstract: The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments. A general representation of the 2-(heteroaryl)amino-riminophenazines is shown below.
    Type: Application
    Filed: May 1, 2014
    Publication date: August 28, 2014
    Applicant: Global Alliance for TB Drug Development
    Inventors: Kai Liu, Christopher B. Cooper, Haihong Huang, Chun Li, Binna Liu, Yang Liu, Zhenkun Ma, Jingbin Wang, Dali Yin, Dongfeng Zhang, Gang Zhang, Hao Zhang
  • Patent number: 8716292
    Abstract: The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments. A general representation of the 2-(heteroaryl)amino-riminophenazines is shown below.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: May 6, 2014
    Assignee: Global Alliance for TB Drug Development
    Inventors: Kai Liu, Christopher B. Cooper, Haihong Huang, Chun Li, Binna Liu, Yang Liu, Zhenkun Ma, Jingbin Wang, Dali Yin, Dongfeng Zhang, Gang Zhang, Hao Zhang
  • Publication number: 20140031354
    Abstract: The present invention relates to compounds of Formula I: as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof, wherein the variables are described herein. The present invention further relates to pharmaceutical compositions which comprise the compounds of Formula I, and to methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.
    Type: Application
    Filed: July 30, 2012
    Publication date: January 30, 2014
    Applicant: Astar Biotech LLC
    Inventors: Chunrong YU, Haihong Huang, Dongfeng Zhang, Peng Li
  • Publication number: 20120071472
    Abstract: The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
    Type: Application
    Filed: June 28, 2011
    Publication date: March 22, 2012
    Applicants: Institute of Materia Medica, Global Alliance for TB Drug Development
    Inventors: Kai Liu, Christopher B. Cooper, Haihong Huang, Chun Li, Binna Liu, Yang Liu, Zhenkun Ma, Jingbin Wang, Dali Yin, Dongfeng Zhang, Gang Zhang, Hao Zhang